文献速递牙体牙髓病

富血小板生长因子联合引导组织再生在牙髓外科中的应用:回顾性队列研究

The Use of Plasma Rich in Growth Factors With Guided Tissue Regeneration in Surgical Endodontics-A Retrospective Cohort Study.
PubMed 文献 · Int Endod J · 2026-09-25

本回顾性队列研究纳入161例牙髓外科患者,比较PRGF联合或不联合GTR技术对软组织愈合、术后反应及疗效的影响。结果显示PRGF单独使用可改善早期软组织愈合,联合胶原膜可减少短期不良反应并维持临床附着水平,但在优化技术标准下PRGF与GTR的优势有限。

要点

  • PRGF单独使用可显著改善拆线时软组织愈合(100.0% vs 79.2%,p=0.013)。
  • PRGF联合Bio-Gide膜可减少拆线时镇痛需求、不良反应及生活质量影响(p<0.001)。
  • PRGF联合Bio-Gide膜在12和24个月维持临床附着水平(p<0.001和p=0.012)。

核心结论

  • PRGF在牙髓外科中的获益取决于是否使用GTR:单独使用改善早期软组织愈合,联合胶原膜减少短期不良反应并维持临床附着。
  • 在优化技术标准下,PRGF与GTR联合应用的优势有限。

研究设计与样本

  • 回顾性队列研究,纳入2018年1月至2024年12月由牙髓专科医师治疗的161例成人患者临床记录。
  • 三个队列比较:队列1(A组无PRGF/GTR n=24 vs B组仅PRGF n=30)、队列2(C组Bio-Gide膜 n=28 vs D组PRGF+Bio-Gide n=26)、队列3(E组Bio-Gide+Bio-Oss n=27 vs F组PRGF+Bio-Gide+Bio-Oss n=26)。
  • 对队列3中大于5 mm的大病变进行亚组分析。

主要发现

  • 队列1中PRGF组拆线时软组织愈合显著优于对照组(100.0% vs 79.2%,p=0.013)。
  • 队列2中PRGF联合Bio-Gide组拆线时镇痛需求、不良反应及生活质量影响显著降低(p<0.001)。
  • 队列2中PRGF联合Bio-Gide组在12个月(p<0.001)和24个月(p=0.012)维持临床附着。
  • 队列3及大病变亚组中PRGF与任何临床或影像学结局均无显著关联(p>0.050)。

关键数值与推荐

  • 软组织愈合质量、临床附着丧失及基于临床和影像学愈合的治疗效果在拆线时及12、24个月随访评估。
  • 术后体征症状、镇痛需求、进一步干预、不良反应及生活质量也被评估。
  • 统计分析采用Pearson卡方或Fisher精确检验,显著性阈值α=0.05。

临床怎么用

  • 牙髓外科中可考虑单独使用PRGF以改善早期软组织愈合。
  • 联合胶原膜使用PRGF可减少短期术后不良反应并维持临床附着水平。
  • 在已有优化技术标准的GTR操作中,附加PRGF的额外获益有限。

局限性

  • 回顾性研究设计可能存在选择偏倚和信息偏倚。
  • 样本量较小且分组非随机,各队列人数有限。
  • 仅评估12和24个月随访,长期效果未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To examine the influence of plasma rich in growth factors (PRGF) with or without guided tissue regeneration (GTR) techniques on soft tissue healing dynamics, postoperative sequelae and treatment outcome in endodontic surgery. METHODOLOGY: In this retrospective study, the clinical records (n = 161) of adult patients treated by an endodontic specialist between January 2018 and December 2024 across three cohorts were reviewed. Cohort 1 compared Group A (no PRGF/GTR; n = 24) with Group B (PRGF only; n = 30); Cohort 2 compared Group C (Bio-Gide membrane; n = 28) with Group D (PRGF + Bio-Gide; n = 26); and Cohort 3 compared Group E (Bio-Gide + Bio-Oss graft; n = 27) with Group F (PRGF + Bio-Gide + Bio-Oss; n = 26). Sub-group analysis was performed for large lesions (> 5 mm) in Cohort 3. Soft tissue healing quality, clinical attachment loss and treatment outcome, based on clinical and radiographic healing, were assessed during suture removal and at 12 and 24 months follow-ups. Additionally, postoperative signs and symptoms, analgesics need, further intervention, adverse effects and quality of life were also evaluated. Statistical analysis was performed with Pearson's chi-square or Fisher's exact tests (significance threshold, α = 0.05). RESULTS: In Cohort 1, PRGF significantly improved soft tissue healing at suture removal (p = 0.013; Group B: 100.0% v. Group A: 79.2%). In Cohort 2, combining PRGF with Bio-Gide significantly reduced the analgesic need, adverse effects and impact on quality of life at suture removal (p < 0.001), and preserved clinical attachment at 12 months (p < 0.001) and 24 months (p = 0.012). For Cohort 3 and large lesions, PRGF had no significant association with any clinical or radiographic outcomes at any stage (p > 0.050). CONCLUSIONS: The benefits of PRGF in endodontic surgery were dependent on the GTR used. When used alone early soft tissue healing was improved, and when combined with a collagen membrane, short-term adverse effects and impact on quality of life were reduced, while maintaining clinical attachment levels. When performed to an optimal technical standard, the advantages of using PRGF and GTR were limited.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Chountala M, Billis G, Shah PK, et al. The Use of Plasma Rich in Growth Factors With Guided Tissue Regeneration in Surgical Endodontics-A Retrospective Cohort Study. Int Endod J. 2026. PMID: 42786944. doi:10.1111/iej.70280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。